Skip to main content

New Products

  • Dr. Reddy's launches generic Antara capsules

    HYDERABAD, India — Dr. Reddy's Labs on Wednesday announced the launch of fenofibrate capsules, USP in 43-mg and 130-mg strengths. The drug is the generic version of Antara (fenofibrate) capsules.

    The Antara capsules brand and generics had U.S. sales of approximately $74 million MAT for the most recent 12 months ending February 2014, according to IMS Health. Dr. Reddy's fenofibrate capsules, USP 43-mg is available in bottle counts of 30; 130-mg are available in bottle counts of 30 and 90.

     

  • Dry Idea launches new StainClear formulation

    SCOTTSDALE, Ariz. — Henkel’s Dry Idea brand has introduced its new Dry Idea Stain Clear.

    The new invisible solid goes on clear and combines stain fighting technology with wetness protection and 72-hour odor coverage, the company stated.

  • PepsiCo adds twisted new addition

    PLANO, Texas — PepsiCo on Tuesday announced the debut of new Twistos Baked Snack Bites to its portfolio. The bites are available in three flavors — bruschetta, parmesan and garlic, and asiago flavors — and can be enjoyed as a standalone snackng item, or as complement to a soup or salad, the company said.

    The brand has teamed up with chef and food writer Gaby Dalkin of "What's Gaby Cooking" to help develop tips for mixing up snack time.

  • NBTY launches new supplement line

    RONKONKOMA, N.Y. — NBTY, a global manufacturer and distributor or vitamins and nutritional supplements, introduced Nature's Origin, the company's first complete line of vitamins, minerals and herbal supplements. The products are available in the United States direct to consumers at NaturesOrigin.com.

  • FDA approves Eli Lilly orphan drug for gastric cancer

    INDIANAPOLIS — Eli Lilly on Monday announced that the Food and Drug Administration has approved Cyramza (ramucirumab) as a single-agent treatment for patients with advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma with disease progression on or after prior fluoropyrimidine- or platinum-containing chemotherapy. With this approval, Cyramza becomes the first FDA-approved treatment for patients in this setting.

  • Mars Chocolate has a ball with latest campaign

    HACKETTSTOWN, N.J. — Mars Chocolate last week announced the introduction of the M-Ball, a peanut M&M's-shaped twist on the traditional soccer ball. The vibrant ball started making the rounds in the United States on April 15, and it comes at a time when soccer fandom is reaching an all-time high, the company said.

  • Pfizer’s new Robitussin capsules bring cough relief on the go

    MADISON, N.J. — Pfizer recently launched Robitussin Maximum Strength Cough + Congestion DM, a new liquid-filled capsule that helps control cough on the go. The new capsule formulation contains 10 mg of dextromethorphan as a cough suppressant and 200 mg of guaifenesin as an expectorant. For adults and children older than 12 years, the new formulation will help temporarily relieve cough due to minor throat and bronchial irritation, and help loosen phlegm and thin bronchial secretions to drain bronchial tubes.

  • FDA approves ofatumumab/chlorambucil combo treatment for chronic lymphocytic leukemia

    LONDON — GlaxoSmithKline and Genmab A/S announced last week that the Food and Drug Administration has approved a supplemental biologic license application for the use of Arzerra (ofatumumab) in combination with chlorambucil for the treatment of previously untreated patients with chronic lymphocytic leukemia for whom fludarabine-based therapy is considered inappropriate.

X
This ad will auto-close in 10 seconds